Webinars

Interact with us

  • Serology

    24.11.2020

    Early stage kinetics and validation of ELISA data

    • High-quality kinetics in a wide range of crude samples ranging from peptides to membrane proteins and relevant clinical samples.
    • WAVE goodbye to lengthy and laborious receptor purification procedures.
    • Welcome contaminants and work with crude samples.
  • Peptides

    24.11.2020

    Binding kinetics supporting peptide discovery

    In collaboration with Pepscan

    • Optimization of peptides for therapeutic and diagnostic purposes.
    • Off-rate screening as a valuable alternative approach to small molecule fragments and peptide selection in drug discovery.
    • GCI technology can be used as orthogonal validation technique for ELISA data.
    • Measuring kinetics in biofluids provides valuable insights into a drug’s efficacy.
    • CLIPS® as a powerful and bio-orthogonal peptide cross linking chemistry.
  • Plant Sciences

    24.11.2020

    Probing signalling interactions by two methods: GCI and ITC

    Biophysical methods applied to signalling interactions, including those in plant sciences by Kelvin Lau (Protein Production and Structure Core Facility (PTPSP, EPFL)

    In this series of virtual seminar, we will walk you through the benefits of the WAVEsystem for plant sciences research. Expect to see high-quality kinetics in the toughest sample conditions!

  • Small Molecules/FBDD

    24.11.2020

    Small molecules: binding kinetics no matter the size

    • Screen, rank and characterize weak binders with off-rates up to 10 s-1.
    • Study binding kinetics even at large analyte:ligand MW ratios (up to 1:1000).
    • Experiment with crude mixtures, detergents and other additives without clogging.
  • Membrane Proteins

    24.11.2020

    Binding kinetics onto membrane proteins

    • Analyze multiprotein complexes and even larger particles like VLPs and crude membranes.
    • WAVE goodbye to lengthy and laborious receptor purification procedures.
    • Welcome contaminants and work with crude samples.
  • Biologics Development

    24.11.2020

    Biochemical and biophysical characterization of biologics

    In collaboration with Shawn Owen (University of Utah)

    • Measuring kinetics in biofluids does provide valuable insights into a drug’s efficacy.
    • How can I best characterize antibody drug conjugates using biochemical and biophysical techniques?
    • Determination of level of payload and site of conjugation of ADCs using LC/MS.
    • Thermal stability and binding affinity of ADCs characterization using DSC, IR, ITC and GCI.
    • What is the Grating-Coupled Interferometry technology?
  • Serology

    24.11.2020

    Biochemical and biophysical characterization of biologics

    In collaboration with Shawn Owen (University of Utah)

    • Measuring kinetics in biofluids does provide valuable insights into a drug’s efficacy.
    • How can I best characterize antibody drug conjugates using biochemical and biophysical techniques?
    • Determination of level of payload and site of conjugation of ADCs using LC/MS.
    • Thermal stability and binding affinity of ADCs characterization using DSC, IR, ITC and GCI.
    • What is the Grating-Coupled Interferometry technology?
  • Biologics Development

    24.11.2020

    Early stage kinetics and validation of ELISA data

    • High-quality kinetics in a wide range of crude samples ranging from peptides to membrane proteins and relevant clinical samples.
    • WAVE goodbye to lengthy and laborious receptor purification procedures.
    • Welcome contaminants and work with crude samples.
  • Peptides

    24.11.2020

    Early stage kinetics and validation of ELISA data

    • High-quality kinetics in a wide range of crude samples ranging from peptides to membrane proteins and relevant clinical samples.
    • WAVE goodbye to lengthy and laborious receptor purification procedures.
    • Welcome contaminants and work with crude samples.
  • Biologics Development

    24.11.2020

    Binding kinetics supporting peptide discovery

    In collaboration with Pepscan

    • Optimization of peptides for therapeutic and diagnostic purposes.
    • Off-rate screening as a valuable alternative approach to small molecule fragments and peptide selection in drug discovery.
    • GCI technology can be used as orthogonal validation technique for ELISA data.
    • Measuring kinetics in biofluids provides valuable insights into a drug’s efficacy.
    • CLIPS® as a powerful and bio-orthogonal peptide cross linking chemistry.